Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-02

Clinical Trial Update: The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating the efficacy of methylprednisolone for ocular involvement in Behçet's disease. The sponsor is Tehran University of Medical Sci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Behcet's Disease | Phase 4 | Status: UNKNOWN